SCHEMBL28290197

SCHEMBL28290197

CCOc1ccc(-c2ccc(C(C)(C)N)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.54
TDP1 Q9NUW8 2/20 0.50
TSHR P16473 1/20 0.50
KDM4E B2RXH2 4/20 0.47
HSD17B10 Q99714 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
TP53 P04637 1/20 0.47
MAPT P10636 4/20 0.46
LMNA P02545 2/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
KIF11 P52732 1/20 0.44
XDH P47989 1/20 0.44
PARP10 Q53GL7 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8629924 0.94 NQO1 (0.61) NQO1TDP1TSHRKDM4EHSD17B10
Hydrochloric Acid SCHEMBL21879623 0.92 NQO1 (0.58) NQO1TDP1TSHRKDM4EHSD17B10
SCHEMBL13761773 0.84 NQO1 (0.58) NQO1TDP1TSHRKDM4ENPC1
SCHEMBL13756272 0.82 NQO1 (0.56) NQO1TDP1TSHRTP53MAPT
SCHEMBL13211694 0.82 NQO1 (0.61) NQO1TDP1TSHRKDM4EHSD17B10
SCHEMBL28291644 0.81 NQO1 (0.50) NQO1TDP1TSHRKDM4EHSD17B10
SCHEMBL18417193 0.81 NQO1 (0.82) NQO1TDP1TSHRKDM4EHSD17B10
SCHEMBL9155582 0.81 NQO1 (0.82) NQO1TDP1TSHRKDM4EHSD17B10
SCHEMBL5833291 0.81 NQO1 (0.82) NQO1TDP1TSHRKDM4EHSD17B10
SCHEMBL9074434 0.81 NQO1 (0.54) NQO1TDP1TSHRKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563103-A modulators of beta-3 adrenergic receptors for the treatment or prevention of disorders related thereto 艾尼纳制药公司 2019-04-02 CN claimed
CN-109563103-A modulators of beta-3 adrenergic receptors for the treatment or prevention of disorders related thereto 艾尼纳制药公司 2019-04-02 CN disclosed